Post
Prof Sam Illingworth
samillingworth.com
did:plc:sgzwcbgta3lha4gmnwvkgvbb
💊 Stomach cancer drug cuts death risk
In a trial of 948 people with stomach cancer in 20 countries, adding durvalumab to chemotherapy before and after surgery cut the risk of dying by 22% versus chemo alone.
🔗 https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)01254-7/fulltext
#Cancer #Oncology #Science 🧪
2026-09-11T04:53:09.163Z